3 clinical trials found.
-
A Phase 2 12-Week Adaptive Open Label Sequential Cohort Trial to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of PF06730512 Following Multiple Doses in Adult Subjects with Focal Segmental Glomerulosclerosis (FSGS)
The purpose of this research study is to learn about the effects, overall safety, how well people can tolerate (tolerability) the study drug (PF-06730512), and ...Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A randomized treatment open-label dose-blinded parallel group three arm proof-of-concept clinical trial to investigate the efficacy and safety of LNP023 compared with rituximab in the treatment of subjects with idiopathic membranous nephropathy
The purpose of the study is to find out if the drug called “LNP023” is safe and has beneficial effects in people who have membranous ...Phase
Interventional
TRIAL ROLE: Sub Investigator
-
A Multicenter Randomized Double-Blind Placebo-Controlled Multiple Dose Study to Evaluate the Efficacy and Safety of VIS649 in Participants with Immunoglobulin A (IgA) Nephropathy
Immunoglobulin A nephropathy is a chronic disease with periodic flares. There are currently no approved therapies for IgAN, and the current treatment strategies consist of ...Phase
Interventional
TRIAL ROLE: Sub Investigator
